"Ounce-equivalents" in the Protein Foods Group: Benefits of Quality
NCT ID: NCT03179462
Last Updated: 2021-12-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
27 participants
INTERVENTIONAL
2017-12-01
2019-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pork intake
Subjects will consume 2 ounces of cooked lean pork following diet normalization for 3 days.
Pork intake
Each participant will consume 2 ounces of cooked lean pork.
Mixed nuts intake
Subjects will consume 1 ounce of mixed nuts following diet normalization for 3 days.
Mixed nuts intake
Each participant will consume 1 ounce of mixed nuts.
Tofu intake
Subjects will consume 2 ounces of tofu following diet normalization for 3 days.
Tofu intake
Each participant will consume 2 ounces of tofu.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pork intake
Each participant will consume 2 ounces of cooked lean pork.
Mixed nuts intake
Each participant will consume 1 ounce of mixed nuts.
Tofu intake
Each participant will consume 2 ounces of tofu.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI from 20 to 29.9 kg/m2
Exclusion Criteria
* History of malignancy in the 6 months prior to enrollment
* History of a chronic inflammatory condition or other chronic diseases (Lupus, HIV/AIDS, etc)
* History of weight reduction surgery (Lapband, gastric sleeve, etc.)
* Pregnant females
* Subjects who do not or will not eat animal proteins
* Subjects allergic to pork, tree or peanuts, or soybeans
* Subjects who cannot refrain from consuming protein or amino acid supplements during their participation in this study
* Subjects who report regular resistance training exercise \> one per week
* Hemoglobin \< 9.5 g/dL at the screening visit
* Platelets \< 250,000 at the screening visit
* Concomitant use of corticosteroids (ingestion, injection or transdermal)
* Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
206579
Identifier Type: -
Identifier Source: org_study_id